Polymyalgia rheumatica following COVID-19 vaccination: A case-series of ten patients
- 22 December 2021
- journal article
- letter
- Published by Elsevier in Joint Bone Spine
- Vol. 89 (2) , 105334
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The Effectiveness of Post-Vaccination and Post-Infection Protection in the Hospital Staff of Three Prague Hospitals: A Cohort Study of 8-Month Follow-Up from the Start of the COVID-19 Vaccination Campaign (COVANESS)Vaccines, 2021
- SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: “Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?” by Manzo et al. Joint Bone Spine 2021;88:105150Joint Bone Spine, 2021
- Polymyalgia rheumatica as uncommon adverse event following immunization with COVID‐19 vaccine: A case report and review of literatureAging Medicine, 2021
- Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?Joint Bone Spine, 2021
- Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 VaccinationVaccines, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Polymyalgia rheumatica following infective triggersor vaccinations: a different subset of disease?Rheumatology, 2020
- 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiativeAnnals of the Rheumatic Diseases, 2012
- Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritisAnnals of the Rheumatic Diseases, 2011